Subjective impressions of stable patients with paranoid schizophrenia after adding to antipsychotic treatment anticholinesterase agent.

被引:0
|
作者
Morozova, M. [1 ]
Rupchev, G. [1 ]
机构
[1] Fed State Budgetary Sci Inst Mental Hlth Res Ctr, Lab Psychopharmacol, Moscow, Russia
关键词
schizophrenia; negative symptoms; add-on treatment; ipidacrine;
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
EPP1111
引用
收藏
页码:S249 / S250
页数:2
相关论文
共 50 条
  • [21] Exploring the mRNA expression level of RELN in peripheral blood of schizophrenia patients before and after antipsychotic treatment
    Jiajun Yin
    Yana Lu
    Shui Yu
    Zhanzhan Dai
    Fuquan Zhang
    Jianmin Yuan
    Hereditas, 157
  • [22] Evaluation of the Efficacy and Safety of Adding Pregabalin to Antipsychotic Treatment in Patients With Chronic Schizophrenia: A Double-blind Placebo-controlled Clinical Trial
    Farnia, Samaneh
    Mahtiyan, Elham
    Zarghami, Mehran
    Parkoohi, Parisa Eslami
    Emadian, Aida
    Hendouei, Narjes
    IRANIAN JOURNAL OF PSYCHIATRY AND CLINICAL PSYCHOLOGY, 2022, 27 (04): : 428 - 439
  • [23] The relation between negative symptoms and reward alterations before and after antipsychotic treatment in first episode patients with schizophrenia
    Nielsen, M. O.
    Wulff, S.
    Rostrup, E.
    Glenthoj, B.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S973 - S974
  • [24] Regional cerebral blood flow in first-episode schizophrenia patients before and after antipsychotic drug treatment
    Livingston, MG
    McCreadie, RG
    Bouch, CJK
    Brown, KW
    Brown, T
    Clark, S
    Corrigan, E
    Crocket, GT
    Graham, J
    Hughson, AVM
    Hunter, R
    Kemp, M
    McKane, J
    Matson, IC
    Reid, J
    Turner, MS
    Waterhouse, J
    Williamson, DJ
    Wood, E
    Berry, A
    Caris, HF
    Dow, MGT
    Greene, JG
    Li, CK
    McGovern, J
    Mahmood, Z
    Scott, AM
    Sim, A
    Weighill, VE
    Hadley, D
    Wiles, D
    Wyper, DJ
    Batchelor, DH
    Rendall, M
    Hammond, G
    ACTA PSYCHIATRICA SCANDINAVICA, 1998, 97 (06) : 440 - 449
  • [25] A Longitudinal MR Spectroscopy Study of the Anterior Cingulate Cortex and Hippocampus Before and After Antipsychotic Treatment in Patients with Schizophrenia
    Reid, Meredith A.
    Kraguljac, Nina V.
    White, David M.
    den Hollander, Jan A.
    Lahti, Adrienne C.
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S170 - S171
  • [26] Subjective well-being, drug attitude, and changes in symptomatology in chronic schizophrenia patients starting treatment with new-generation antipsychotic medication
    Christian G. Widschwendter
    Georg Kemmler
    Maria A. Rettenbacher
    Nursen Yalcin-Siedentopf
    Alex Hofer
    BMC Psychiatry, 18
  • [27] Subjective well-being, drug attitude, and changes in symptomatology in chronic schizophrenia patients starting treatment with new-generation antipsychotic medication
    Widschwendter, Christian G.
    Kemmler, Georg
    Rettenbacher, Maria A.
    Yalcin-Siedentopf, Nursen
    Hofer, Alex
    BMC PSYCHIATRY, 2018, 18
  • [28] Subjective response and attitudes toward antipsychotic drug therapy during the initial treatment period: a prospective follow-up study in patients with schizophrenia
    Hofer, A.
    Rettenbacher, M. A.
    Edlinger, M.
    Kemmler, G.
    Widschwendter, C. G.
    Fleischhacker, W. W.
    ACTA PSYCHIATRICA SCANDINAVICA, 2007, 116 (05) : 354 - 361
  • [29] Improvement of cognitive function after treatment with atypical antipsychotic drugs in patients with schizophrenia: P300 and LORETA analyses
    Morita, K.
    Shoji, Y.
    Hirai, S.
    Ishii, Y.
    Maeda, H.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S159 - S160
  • [30] GLUTAMATE AND GABA LEVELS IN ANTIPSYCHOTIC-NAIVE SCHIZOPHRENIA PATIENTS ARE ASSOCIATED WITH TREATMENT OUTCOME AFTER 1.5 AND 6 MONTHS
    Bojesen, Kirsten
    Broberg, Brian
    Jessen, Kasper
    Sigvard, Anne
    Tangmose, Karen
    Nielsen, Mette Odegaard
    Rostrup, Egill
    Glenthoj, Birte
    SCHIZOPHRENIA BULLETIN, 2018, 44 : S224 - S225